MYCT1 Antibody (C-term)
Affinity Purified Rabbit Polyclonal Antibody (Pab)
- 产品详情
- 实验流程
- 背景知识
Application ![]()
| WB, FC, E |
---|---|
Primary Accession | Q8N699 |
Other Accession | NP_079383.2 |
Reactivity | Human |
Host | Rabbit |
Clonality | Polyclonal |
Isotype | Rabbit IgG |
Calculated MW | 26593 Da |
Antigen Region | 135-163 aa |
Gene ID | 80177 |
---|---|
Other Names | Myc target protein 1, Myc target in myeloid cells protein 1, MYCT1, MTLC, MTMC1 |
Target/Specificity | This MYCT1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 135-163 amino acids from the C-terminal region of human MYCT1. |
Dilution | WB~~1:1000 FC~~1:10~50 E~~Use at an assay dependent concentration. |
Format | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
Precautions | MYCT1 Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | MYCT1 |
---|---|
Synonyms | MTLC, MTMC1 |
Function | May regulate certain MYC target genes, MYC seems to be a direct upstream transcriptional activator. Does not seem to significantly affect growth cell capacity. Overexpression seems to mediate many of the known phenotypic features associated with MYC, including promotion of apoptosis, alteration of morphology, enhancement of anchorage-independent growth, tumorigenic conversion, promotion of genomic instability, and inhibition of hematopoietic differentiation (By similarity). |
Cellular Location | Nucleus. Note=Expressed in nuclei of hepatocellular carcinoma cell line BEL-7402 cells |
Tissue Location | Down-regulated in gastric cancer tissues. |
For Research Use Only. Not For Use In Diagnostic Procedures.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
May regulate certain MYC target genes, MYC seems to be a direct upstream transcriptional activator. Does not seem to significantly affect growth cell capacity. Overexpression seems to mediate many of the known phenotypic features associated with MYC, including promotion of apoptosis, alteration of morphology, enhancement of anchorage-independent growth, tumorigenic conversion, promotion of genomic instability, and inhibition of hematopoietic differentiation (By similarity).
REFERENCES
Qiu, G.B., et al. World J. Gastroenterol. 9(10):2160-2163(2003)
Qiu, G., et al. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 20(2):94-97(2003)

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。
如有疑问,联系:0512-88856768 tech-china@abcepta.com.